Correlation Between INmune Bio and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Alzamend Neuro, you can compare the effects of market volatilities on INmune Bio and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Alzamend Neuro.
Diversification Opportunities for INmune Bio and Alzamend Neuro
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between INmune and Alzamend is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of INmune Bio i.e., INmune Bio and Alzamend Neuro go up and down completely randomly.
Pair Corralation between INmune Bio and Alzamend Neuro
Given the investment horizon of 90 days INmune Bio is expected to generate 0.36 times more return on investment than Alzamend Neuro. However, INmune Bio is 2.79 times less risky than Alzamend Neuro. It trades about -0.05 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.02 per unit of risk. If you would invest 1,126 in INmune Bio on August 25, 2024 and sell it today you would lose (639.00) from holding INmune Bio or give up 56.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
INmune Bio vs. Alzamend Neuro
Performance |
| Timeline |
| INmune Bio |
| Alzamend Neuro |
INmune Bio and Alzamend Neuro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with INmune Bio and Alzamend Neuro
The main advantage of trading using opposite INmune Bio and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.| INmune Bio vs. Eliem Therapeutics | INmune Bio vs. HCW Biologics | INmune Bio vs. Scpharmaceuticals | INmune Bio vs. Milestone Pharmaceuticals |
| Alzamend Neuro vs. Eliem Therapeutics | Alzamend Neuro vs. HCW Biologics | Alzamend Neuro vs. Scpharmaceuticals | Alzamend Neuro vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world |